ahlam1399
03-07-2016, 11:13 PM
BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study.Two doses of the drug, BCX443, were tested against a placebo and an oral...http://feeds.feedburner.com/~r/com/YEor/~4/D02LiQd-99s
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/D02LiQd-99s/103520-BioCrysts-Zika-drug-shows-promise-in-mice)
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/D02LiQd-99s/103520-BioCrysts-Zika-drug-shows-promise-in-mice)